(-)-trans 3′-Aminomethyl Nicotine is one of Nicotine derivatives, which is a potent parasympathomimetic stimulant.

(-)-trans-anti-N2-BPDE-dG is used in the study of carcinogen-DNA adducts and their role in affecting eukaryotic DNA methyltransferases. Cluster-type DNA damage is often seen in DNA and is usually skipped by base excision repair.

(-)-Tranylcypromine-[d5] Hydrochloride, is the labelled analogue of Tranylcypromine. Tranylcypromine is a monoamine oxidase inhibitor.

(-)-U-50488 hydrochloride is the more active enantiomer of (±)-U-50488, which is an opioid receptor agonist.

(-)-Variabilin is a phenolic compound found in the herbs of Angelica sinensis. (-)-Variabilin exhibits activity of antimicrobial and is an important chemotaxonomic marker for the family Irciniidae.

(-)-WAY 100135 dihydrochloride is a selective serotonin 5-HT1A antagonist.

(−)-WIN 55,212-3 is an aminoalkylindole derivative which acts as a competitive neutral antagonist of the human cannabinoid CB2 receptor and presumably express the CB1 receptor. It also weakly antagonizes the melatonin MT1 and muscarinic M4 receptors but has no effect on several other G protein-coupled receptors.

(-)-Xestospongin C is a potent and reversible inhibitor of IP3 receptor that reguates calcium release. (-)-Xestospongin C has been found to inhibit bradykinin-induced Ca2+ release in PC12 cells and attenuate PHP-induced IL-2 production in Jurkat T cells, but exhibits no effect on ryanodine receptor-mediated Ca2+ release in PC12 cells.

(((((2R,3R,4S,5R)-5-(2-Chloro-6-(cyclopentylamino)-9H-purin-9-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic Acid acts as a modulating agent for 5′-nucleotidase and may be applied to chemotherapeutic and anti-inflammatory treatments.

It is an impurity of paricalcitol, an analogue of vitamin D2. Paricalcitol is a medication used for the treatment of secondary hyperparathyroidism.

(((3aS,5aR,8aR,8bS)-2,2,7,7-Tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4′,5′-d]pyran-3a-yl)methyl)-L-arginine is an intermediate in the synthesis of Fructose L-Arginine Adduct (F795650) which is an analogue of Fructose-leucine, an amadori compound having the potential to alter cellular adhesion, inhibit cancer metastasis and induce apoptosis.

((1-[(4-Methyl-1-piperazinyl)methyl]cyclopropyl)methyl)amine (CAS# 1015846-52-2) is a useful research chemical.

((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane is an intermediate for the synthesis of 3-Hydroxy Bortezomib (H818150), which is a metabolite of Bortezomib (B675700); the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.

((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine is an intermediate int he synthesis of Tasimelteon (T007740), a novel drug, used in the treatment of non-24 hour sleep-wake disorder. It helps to correct the circadian rhythm disorder often seen in patients who are visually impaired.

((1R,3R)-3-Amino-cyclopentyl)-carbamic Acid tert-Butyl Ester is used in the preparation of quinoline-3-carboxoamides as H-PGDS inhibitors as well as novel triazolo-pyrrolopyridines as Janus kinase 1 inhibitors.

Intermediate in the production of Rho kinase inhibitors and neurite outgrowth promoters.

[[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl-phosphonium Bromide is an impurity in the production of Pitavastatin, which is a potent HMG-CoA reductase inhibitor for hypercholesterolemia (elevated cholesterol) and prevention of cardiovascular disease.

An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir.

((2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-(2-(trimethylsilyl)ethoxy)tetrahydro-2H-pyran-2-yl)methyl 4-Methylbenzenesulfonate is an intermediate in the synthesis of N-((2S,3R,4R,6R)-2,4-Dihydroxy-6-methyl-5-oxotetrahydro-2H-pyran-3-yl)acetamide (D468230).

((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate is an intermediate in the synthesis of 3-Deazauridine-5′-triphosphate Triethylamine Salt (D203245), which is the active metabolite of the anticancer drug 3-Deazauridine (D203240) and can suppress cytidine triphosphate synthetase activity in tumor cells.

((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Dihydrogen Phosphate is an intermediate in the synthesis of 3-Deazauridine-5′-triphosphate Triethylamine Salt (D203245), which is the active metabolite of the anticancer drug 3-Deazauridine (D203240) and can suppress cytidine triphosphate synthetase activity in tumor cells.

((2R,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate is an intermediate in the synthesis of Itraconazole (I937500), an orally active antimycotic structurally related to Ketoconazole. Antifungal.

((2R,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate is an intermediate in the synthesis of Itraconazole (I937500), an orally active antimycotic structurally related to Ketoconazole. Antifungal.